5 unchanged sentences
(c) Purchases of Equity Securities by the Issuer
+Added: Total Number of Shares Purchases
+Added: Average Price Paid per Share
+Added: Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
+Added: Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs (1)
+Added: January 1, 2026 to January 31, 2026
+Added: February 1, 2026 to February 28, 2026
+Added: March 1, 2026 to March 31, 2026
+Added: (1) On November 3, 2025, the Board of Directors of Innoviva authorized a share repurchase program under which we may repurchase up to $125.0 million of our outstanding shares of common stock.
+Added: The repurchase program authorized the repurchase by the Company of its common stock in open market transactions, including pursuant to a trading plan in accordance with Rule 10b-18 promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), privately negotiated transactions, in block trades, accelerated share repurchase transactions, exchange transactions, or any combination thereof or by other means in accordance with federal securities laws.
+Added: The authorization permitted management to repurchase shares of the Company’s common stock from time to time at management’s discretion.
+Added: Repurchases may also be made pursuant to a trading plan under Rule 10b5-1 under the Exchange Act, which would permit shares to be repurchased when the Company might otherwise be precluded from doing so because of self-imposed trading blackout periods or other regulatory restrictions.
D efaults Upon Senior Securities
2 unchanged sentences
Trading Arrangements
−Removed: None of the Company’s directors or officers adopted , modified , or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement during the quarter ended September 30, 2025, as such terms are defined in Item 408(a) of Regulation S-K.
+Added: None of the Company’s directors or officers adopted , modified , or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement during the quarter ended March 31, 2026, as such terms are defined in Item 408(a) of Regulation S-K.
(a) Index to Exhibits
3 unchanged sentences
Specimen certificate representing the common stock of the registrant
−Removed: Form of 2.125% Convertible Subordinated Note Due 2023 (included in Exhibit 4.2)
−Removed: Indenture (including form of Note) with respect to Innoviva’s 2.5% Convertible Senior Notes due 2025, dated as of August 7, 2017, between Innoviva and The Bank of New York Mellon Trust Company, N.A., as trustee
Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
14 unchanged sentences
Innoviva, Inc.
−Removed: November 5, 2025
/s/ Pavel Raifeld
2 unchanged sentences
(Principal Executive Officer)
−Removed: November 5, 2025
/s/ Stephen Basso
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.